Clinical Trials Directory

Trials / Completed

CompletedNCT01783093

Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia

An Evaluation of Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Patients With Sickle Cell Anemia: A Retrospective Data Review

Status
Completed
Phase
Study type
Observational
Enrollment
209 (actual)
Sponsor
Namita Sood · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate patients with pulmonary hypertension and sickle cell disease who have had multiple echocardiograms. Previous studies have shown that an elevated tricuspid jet (TR) regurgitant velocity on echo in this population is a predictor of mortality. This initial data only examined an isolated TR jet velocity. It was presumed that the mortality was related to pulmonary hypertension. It is the aim of this study to retrospectively evaluate patients who have had multiple echocardiograms and to determine if patients who had either a normalization of their TR jet velocity on a subsequent echo or had no evidence of pulmonary hypertension on right heart catheterization had a similar mortality rate to those with persistently elevated TR jet velocity.

Conditions

Interventions

TypeNameDescription
OTHERData CollectionCollection of data from existing medical records

Timeline

Start date
2009-12-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2013-02-04
Last updated
2013-02-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01783093. Inclusion in this directory is not an endorsement.